MedTrace Logo

Genes, Omega-3 Fatty Acids and Cardiovascular Disease Risk Factors

NCT01343342 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2025-12-26

No results posted yet for this study

Summary

The main purpose of this study is to examine whether n-3 PUFA-induced changes in metabolic risk factors are influenced by genetic variations within genes acting as fatty acids sensors.

Conditions

Interventions

DIETARY_SUPPLEMENT

n-3 PUFA supplementation

3g per day of n-3 PUFA supplementation (1.9g EPA, 1.1g DHA). 5 capsules per day (1g fish oil each, 5g of fish oil/day)

Sponsors & Collaborators

  • Laval University

    lead OTHER

Principal Investigators

  • Marie-Claude Vohl, Ph.D. · Institute of Nutraceutical and Functional Foods (INAF), Laval University

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2011-12-31
Completion
2026-03-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01343342 on ClinicalTrials.gov